With the intent of characterizing the molecular mechanisms underlying the biological and prognostic role played by dyskerin in human breast carcinomas, the present study initially aimed at identifying genes whose expression is modulated by dyskerin in breast cancer-derived cells. This evidence concerns the gene DKC1 and breast cancer.